Voss Capital’s LifeMD LFMD Stock Holding History

Voss Capital’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-120,000	Closed	-$1.9M	–	45
2021 Q1	$1.9M	Buy	+120,000	New	+$2.16M	0.79%	33

Other funds holding LFMD

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

BIA

Barry Investment Advisors New Bedford, Massachusetts $478M AUM 23.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voss Capital's LFMD Position: Q2 2021 in Review

Voss Capital sold out of LifeMD (LFMD) in Q2 2021, closing a stake of 120,000 shares — an estimated $1.9M sold.

Voss Capital first reported a position in LFMD in Q1 2021 and held it in 1 quarter. The position peaked at $1.9M in Q1 2021. 63 funds tracked by Wall St. Rank hold LFMD as of Q2 2021.

Voss Capital reported no remaining LifeMD position as of Q2 2021 after selling out during the quarter.
Voss Capital sold 120,000 LifeMD shares in Q2 2021, an estimated $1.9M.
Voss Capital first reported a position in LifeMD in Q1 2021 and held it in 1 quarter.
Voss Capital's LifeMD position peaked at $1.9M in Q1 2021.
63 funds tracked by Wall St. Rank held LifeMD as of Q2 2021.

Based on Voss Capital's 13F filing for Q2 2021, filed 13 Aug 2021.